Tonix Pharmaceuticals Holding Corp (TNXP)
0.1683
+0.01
(+5.19%)
USD |
NASDAQ |
Apr 26, 16:00
0.17
0.00 (0.00%)
After-Hours: 20:00
Tonix Pharmaceuticals Free Cash Flow (Quarterly): -22.78M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -22.78M |
| September 30, 2023 | -25.20M |
| June 30, 2023 | -25.21M |
| March 31, 2023 | -36.71M |
| December 31, 2022 | -26.97M |
| September 30, 2022 | -32.36M |
| June 30, 2022 | -35.61M |
| March 31, 2022 | -51.26M |
| December 31, 2021 | -48.07M |
| September 30, 2021 | -20.70M |
| June 30, 2021 | -20.54M |
| March 31, 2021 | -21.56M |
| December 31, 2020 | -18.45M |
| September 30, 2020 | -19.30M |
| June 30, 2020 | -10.06M |
| March 31, 2020 | -9.326M |
| December 31, 2019 | -6.688M |
| September 30, 2019 | -6.647M |
| June 30, 2019 | -4.716M |
| March 31, 2019 | -8.649M |
| December 31, 2018 | -6.823M |
| September 30, 2018 | -4.894M |
| June 30, 2018 | -5.487M |
| March 31, 2018 | -6.773M |
| December 31, 2017 | -4.93M |
| Date | Value |
|---|---|
| September 30, 2017 | -5.047M |
| June 30, 2017 | -4.362M |
| March 31, 2017 | -4.794M |
| December 31, 2016 | -5.441M |
| September 30, 2016 | -8.392M |
| June 30, 2016 | -7.996M |
| March 31, 2016 | -15.55M |
| December 31, 2015 | -11.96M |
| September 30, 2015 | -12.36M |
| June 30, 2015 | -9.391M |
| March 31, 2015 | -9.053M |
| December 31, 2014 | -8.343M |
| September 30, 2014 | -5.018M |
| June 30, 2014 | -5.732M |
| March 31, 2014 | -4.066M |
| December 31, 2013 | -3.538M |
| September 30, 2013 | -2.871M |
| June 30, 2013 | -0.761M |
| March 31, 2013 | -1.362M |
| December 31, 2012 | -1.506M |
| September 30, 2012 | -1.302M |
| June 30, 2012 | -1.164M |
| March 31, 2012 | -1.778M |
| December 31, 2011 | -1.467M |
| September 30, 2011 | -0.5585M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-51.26M
Minimum
Mar 2022
-4.716M
Maximum
Jun 2019
-23.27M
Average
-21.56M
Median
Mar 2021
Free Cash Flow (Quarterly) Benchmarks
| PetVivo Holdings Inc | -1.477M |
| Acurx Pharmaceuticals Inc | -4.198M |
| ACADIA Pharmaceuticals Inc | 85.39M |
| Kezar Life Sciences Inc | -18.98M |
| Allakos Inc | -24.23M |